2018 HF Board Review Course

27 - HFpEF, Epidemiology, Co-morbidities and Phenomapping

Aug 18, 2018 3:30pm ‐ Aug 18, 2018 4:00pm

Credits: None available.


  • Sanjiv J. Shah, MD, Professor of MedicineDirector, T1 Center for Cardiovascular Developmental TherapeuticsDirector, Northwestern HFpEF ProgramDivision of Cardiology, Department of MedicineNorthwestern University Feinberg School of MedicineNorthwestern UniversityChicago, Speaker


  • Sanjiv Shah, MD:
    • Research Grant-Actelion; AstraZeneca; Bayer; Novartis
    • Consultant-Advisory Board-Actelion; Amgen; AstraZeneca; Bayer; BMS; Boehringer-Ingleheim; Cardiora; Eisai; Ironwood; Merck; Novartis; Sanofi; Tenax Therapeutics; United Therapeutics
    • Institution- Northwestern University


  • 0.50 - CME
  • 0.50 - MOC

You must be logged in and own this session in order to post comments.